CLOV vs MCRB · rev $1.37B vs rev $126.3M
Clover Health Investments Corp (CLOV) versus Seres Therapeutics Inc (MCRB) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Seres Therapeutics Inc (MCRB) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported MCRB revenue for 2023-12-31 was $126.3M. Net income was -$113.7M. Revenue was up 1672.2% from 2022-12-31 to 2023-12-31. MCRB currently screens at market cap $109.8M.
CLOV currently screens at market cap $1.55B. MCRB currently screens at market cap $109.8M.
Not investment advice. Open the CLOV and MCRB stock pages for the full models.
Not investment advice.